APINACA

Uses your system voice; voice and rate in settings.

Snapshot

≈ 4 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

APINACA (AKB48, N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide) is a drug that acts as a reasonably potent agonist for the cannabinoid receptors. It is a full agonist at CB 1 with an EC 50 of 142 nM and K i of 3.24 nM (compared to the K i of Δ 9 -THC at 28.35 nM and JWH-018 at 9.62 nM), while at CB 2 it acts as a partial agonist with an EC 50 of 141 nM and K i of 1.68 nM (compared to the K i of Δ 9 -THC at 37.82 nM and JWH-018 at 8.55 nM). Its pharmacological characterization has also been reported in a discontinued patent application. It had never previously been reported in the scientific or patent literature, and was first identified by laboratories in Japan in March 2012 as an ingredient in synthetic cannabis smoking blends, along with a related compound APICA. It was deliberately being sold named after a popular girl band called AKB48. Structurally, it closely resembles cannabinoid compounds from a 2003 University of Connecticut patent, but with a simple pentyl chain on the indazole 1-position, and APINACA falls within the claims of this patent despite not being disclosed as an example.

APINACA (AKB48, N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide) is a drug that acts as a reasonably potent agonist for the cannabinoid receptors. It is a full agonist at CB 1 with an EC 50 of 142 nM and K i of 3.24 nM (compared to the K i of Δ 9 -THC at 28.35 nM and JWH-018 at 9.62 nM), while at CB 2 it acts as a partial agonist with an EC 50 of 141 nM and K i of 1.68 nM (compared to the K i of Δ 9 -THC at 37.82 nM and JWH-018 at 8.55 nM). Its pharmacological characterization has also been reported in a discontinued patent application. It had never previously been reported in the scientific or patent literature, and was first identified by laboratories in Japan in March 2012 as an ingredient in synthetic cannabis smoking blends, along with a related compound APICA. It was deliberately being sold named after a popular girl band called AKB48. Structurally, it closely resembles cannabinoid compounds from a 2003 University of Connecticut patent, but with a simple pentyl chain on the indazole 1-position, and APINACA falls within the claims of this patent despite not being disclosed as an example.

Legality

APINACA was made illegal in Japan in 2012, and was banned as a temporary class drug in New Zealand from 13 July 2012. APINACA has been banned in Latvia since 14 November 2013. Since 2013, APINACA has been a Schedule I controlled substance in the United States. It is also banned in Germany as an Anlage II controlled drug. APINACA is listed in the Fifth Schedule of the Misuse of Drugs Act (MDA) and therefore illegal in Singapore as of May 2015. As of October 2015 APINACA is a controlled substance in China. APINACA is banned in the Czech Republic.

Detection

A forensic standard of APINACA is available, and the compound has been posted on the Forendex website of potential drugs of abuse.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1364005672 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

8 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.